Trial Profile
Study assessing the effect of entecavir therapy in a cohort of hepatitis B virus (HBV) compensated cirrhosis patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Adefovir dipivoxil; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Mar 2016 New trial record
- 20 Jul 2015 Interim results (n=91) published in the Chinese Medical Journal